Grey Wolf Health Corp. (TSXV:WOLF)

Canada · Delayed Price · Currency is CAD

1.590

-0.110 (-6.47%)

Jul 27, 2026, 11:29 AM EST

Grey Wolf Health Financials Overview

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	36.6	35.76	26.83	25.41	22.64	13.1
Revenue Growth	27.49%	33.30%	5.58%	12.26%	72.85%	-
Gross Profit	19.63	19.06	13.76	12.83	11.56	7.15
Operating Income	4.22	4.06	1.91	1.55	-0.36	0.07
Net Income	1.77	1.66	0.7	0.61	2.54	-0.97
Earnings Per Share	0.06	0.05	0.02	0.02	0.15	-0.07
EPS Growth	106.45%	150.00%	0%	-86.84%	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Animal Health	13.41	13.03	12.14	11.91	11.02	9.77
Pharmacy	23.19	22.73	14.69	13.5	11.61	3.33
Total	36.6	35.76	26.83	25.41	22.64	13.1

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8.77	7.67	6.41	7.78	6.86	4.35
Total Debt	24.96	25.47	27.6	9.92	11.03	21.91
Net Cash (Debt)	-16.19	-17.81	-21.19	-2.14	-4.17	-17.56
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.46	-0.50	-0.66	-0.07	-0.25	-1.26

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	4.31	3.83	1.75	2.43	-0.71	2.14
Capital Expenditures	-0.45	-0.52	-0.53	-0.28	-0.05	-0.01
Free Cash Flow	3.86	3.31	1.21	2.15	-0.76	2.12
Free Cash Flow Growth	-1.98%	173.19%	-43.58%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	53.63%	53.30%	51.28%	50.48%	51.09%	54.59%
Operating Margin	11.53%	11.34%	7.10%	6.12%	-1.57%	0.54%
Pretax Margin	7.01%	6.65%	5.19%	4.32%	7.72%	-14.44%
Profit Margin	4.85%	4.63%	2.63%	2.40%	11.24%	-7.40%
FCF Margin	10.54%	9.26%	4.52%	8.46%	-3.38%	16.22%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	30.68	26.40	55.50	37.00	5.13	-
P/FCF Ratio	14.21	13.63	31.30	10.68	-	-
PS Ratio	1.50	1.26	1.41	0.90	1.07	-